SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-030066
Filing Date
2022-11-01
Accepted
2022-11-01 09:00:09
Documents
4
Period of Report
2022-10-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 38278
2 ex3-1.htm EX-3.1 105211
3 ex10-1.htm EX-10.1 38009
4 ex99-1.htm EX-99.1 13235
  Complete submission text file 0001493152-22-030066.txt   196073
Mailing Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850
Business Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850 2404034212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 221348652
SIC: 2834 Pharmaceutical Preparations